Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT05172765

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05172765
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05172765. Randomized; double masking; primary purpose treatment. Start 2022-09-14 (actual); primary completion 2025-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Transcutaneous Electrical Nerve Stimulation Device
Lead sponsor
University of Oklahoma (class: other)

Record details

Record id
cardio:ct-nct05172765
Content hash
85a20afd911a84d0fc16465759f0693fd2d3112c2572181c15f2e4d606de2619